Rho Vice President and Senior Medical Officer Jack Modell Named to Board of Directors for the Carolinas Chapter of the National Diversity Council
Chapel Hill, NC ̶ March 9, 2017 ̶ Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, recently announced that Jack Modell, M.D., Vice President and Senior Medical Officer at Rho, was named as a board member for the Carolinas Chapter of the National Diversity Council (NDC).
The NDC is a national non-partisan nonprofit organization dedicated to providing resources and advocacy for the value of diversity and inclusion. Dr. Modell joins NDC Carolinas, the chapter of the organization committed to fostering a learning environment for organizations to grow and leverage their knowledge of diversity in North and South Carolina.
“It is an honor to be named as a board member for NDC Carolinas,” said Modell. “Our core values of integrity, quality, teamwork and innovation serve as guiding principles for the Rho team. These values directly align with the mission and vision of NDC Carolinas, and I look forward to contributing to building workplace communities into environments where people are valued and respected for their uniqueness.”
Dr. Modell joins two other board members who will provide support and guidance in carrying out the organization’s mission.
To learn more about Rho, please visit www.rhoworld.com.
Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of clinical research services across the entire drug development process. For more than 33 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. Please follow us on Twitter.